Amit M. Oza, MD
Amit M. Oza, MD
Staff; Clinician Scientist; and Professor
University Health Network, Princess Margaret Hospital
R. Fraser Elliott Building, 1st Floor
190 Elizabeth St.
Toronto,
ON
Canada
M5G 2C4
Papers:
8
A randomized double-blind phase III trial comparing vintafolide (EC145) and pegylated liposomal doxorubicin (PLD/Doxil®/Caelyx®) in combination versus PLD in participants with platinum-resistant ovarian cancer (PROCEED) (NCT01170650)
Advanced/Recurrent endometrial cancer
Tumor BRCA mutation or high genomic LOH identify ovarian cancer patients likely to respond to rucaparib: interim results for ARIEL2 clinical trial